Globus Medical Inc (GMED)
74.88
+1.34
(+1.82%)
USD |
NYSE |
Nov 01, 16:00
74.87
-0.01
(-0.01%)
After-Hours: 20:00
Globus Medical Revenue (Quarterly): 629.69M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 629.69M |
| March 31, 2024 | 606.67M |
| December 31, 2023 | 616.53M |
| September 30, 2023 | 383.64M |
| June 30, 2023 | 291.62M |
| March 31, 2023 | 276.69M |
| December 31, 2022 | 274.50M |
| September 30, 2022 | 254.15M |
| June 30, 2022 | 263.65M |
| March 31, 2022 | 230.55M |
| December 31, 2021 | 250.02M |
| September 30, 2021 | 229.72M |
| June 30, 2021 | 251.02M |
| March 31, 2021 | 227.34M |
| December 31, 2020 | 233.44M |
| September 30, 2020 | 216.10M |
| June 30, 2020 | 148.92M |
| March 31, 2020 | 190.58M |
| December 31, 2019 | 211.67M |
| September 30, 2019 | 196.22M |
| June 30, 2019 | 194.54M |
| March 31, 2019 | 182.95M |
| December 31, 2018 | 195.94M |
| September 30, 2018 | 169.24M |
| June 30, 2018 | 173.38M |
| Date | Value |
|---|---|
| March 31, 2018 | 174.41M |
| December 31, 2017 | 176.03M |
| September 30, 2017 | 151.74M |
| June 30, 2017 | 152.39M |
| March 31, 2017 | 155.81M |
| December 31, 2016 | 151.59M |
| September 30, 2016 | 135.65M |
| June 30, 2016 | 137.49M |
| March 31, 2016 | 139.26M |
| December 31, 2015 | 142.59M |
| September 30, 2015 | 136.99M |
| June 30, 2015 | 133.57M |
| March 31, 2015 | 131.60M |
| December 31, 2014 | 128.80M |
| September 30, 2014 | 117.79M |
| June 30, 2014 | 113.57M |
| March 31, 2014 | 114.21M |
| December 31, 2013 | 115.24M |
| September 30, 2013 | 107.19M |
| June 30, 2013 | 107.01M |
| March 31, 2013 | 105.02M |
| December 31, 2012 | 100.54M |
| September 30, 2012 | 94.76M |
| June 30, 2012 | 95.98M |
| March 31, 2012 | 94.72M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
148.92M
Minimum
Jun 2020
629.69M
Maximum
Jun 2024
304.55M
Average
251.02M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| Stryker Corp | 5.494B |
| Abbott Laboratories | 10.64B |
| Alphatec Holdings Inc | 150.72M |
| Orthofix Medical Inc | 198.62M |
| Insulet Corp | 488.50M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 31.76M |
| Total Expenses (Quarterly) | 565.57M |
| EPS Diluted (Quarterly) | 0.23 |
| Enterprise Value | 10.08B |
| Gross Profit Margin (Quarterly) | 58.70% |
| Profit Margin (Quarterly) | 5.04% |
| Earnings Yield | 0.40% |
| Operating Earnings Yield | 1.71% |
| Normalized Earnings Yield | 1.272 |